ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Lung cancer patients lacking MSH2 DNA repair protein fare better with chemo
Dr Pierre Fouret - Institut Gustave Roussy, France
Targeting death receptors in chemo-resistant cancer cells
Prof Patrick Johnston - Queen's University Belfast, UK
ASCO: Pemetrexed extends survival as maintenance therapy
Dr. Chandra P. Belani - Penn State Cancer Institute, Hershey, Pennsylvania, USA
ASCO: Lung cancer screening by low-dose computed tomography results in high rate...
Dr. Jennifer M. Croswell - National Institutes of Health, Bethesda, Maryland, US...
ASCO: Maintenance therapy for NSCLC
Dr. Vincent A. Miller - MD Memorial Sloan-Kettering Cancer Center, New York, US...
ASCO: Experimental targeted therapy improves progression-free survival for advan...
Dr Roy Herbst, M.D. Anderson Cancer Center, Houston, US
Oestrogen and progestin therapy increases NSCLC risk
Dr Rowan Chlebowski - Harbor-UCLA Medical Center, Los Angeles, US
AACR 2009: Common genetic variations and predisposition to cancer
Prof Bruce Ponder - Cancer Research UK, Cambridge Institute
AACR 2009: 100 years of AACR
Dr Margaret Foti - CEO of the American Association for Cancer Research
AACR 2009: Genetics of pleuropulmonary blastoma
Dr Dana Ashley Hill - Chief of Anatomic Pathology, Children's National Medical C...
Bacteria as agents to initiate potent anti-tumour activity
Dr Maria Rescigno - Deptartment of Experimental Oncology, European Institute of ...
COSMOS lung cancer study
Dr Giulia Veronesi - Deputy Director of the Division of Thoracic Surgery at the ...